Subscription to The Medical Letter
The Medical Letter On Drugs and Therapeutics is a biweekly publication that provides:
  • Evidence-based, peer-reviewed evaluations of new FDA-approved drugs with conclusions reached by a consensus of experts
  • New information on previously approved drugs including pivotal clinical trials, new indications, and safety warnings
  • Consensus recommendations for the preferred and alternative treatments for common disorders
  • Comparative reviews of drugs for a given indication with particular attention to clinical efficacy, adverse effects, drug interactions, and cost
Watch the video!
View Sample Issues: English, Canadian English, French Canadian
Reader Testimonials
Our editorial process relies on a consensus of experts to ensure the information in our articles is presented in a balanced and scientifically supported manner.
Subscriptions to The Medical Letter include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE – Up to 52 credits annually, including ABIM MOC points
Subscribe
Select an Option
Individual
For personal use only. Excludes corporate and institutional use.  $159/year
The Medical Letter Site License
For corporate and institutional use.
Other Medical Letter Products:
Discover potentially life-threatening interactions. Subscribe to Drug Interactions from The Medical Letter.
Earn up to 52 CME/CE credits/year. Purchase CME/CE Exams.
Want to stay organized? Get a personalized Binder to hold your newsletters.
Want to have physical copies of past issues? Purchase a Bound Volume.
Want electronic copies of all articles published since 1988? Purchase the Searchable Collection.